AMGN vs FLEX · P/E 24, rev $36.75B vs P/E 23, rev $6.40B
Amgen Inc (AMGN) versus Flex Ltd (FLEX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Flex Ltd (FLEX) is a electronic components company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Not investment advice. Open the AMGN and FLEX stock pages for the full models.
Not investment advice.